INKT$11.040.00%
MiNK Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$56.34M
Float & O/S:
Inst Own:
DilutionScan read 30 of MiNK Therapeutics, Inc.'s SEC filings and found 1 convertible, 1 ATM program and 3 shelf registrations on file for INKT. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 7, 2026.